How Pharmacists Can Make an Impact When Treating Dedifferentiated Liposarcoma With Brigimadlin
November 11th 2024Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.
Read More
Tackling the Growing Impact of Orphan Drug Designation and Limited Distribution Networks in Oncology
November 8th 2024Pharmacy teams are learning to adapt to the challenges of limited distribution networks and orphan drug designation in oncology, with integrated pharmacy support playing a crucial role in enhancing patient access and adherence.
Read More
Opioid Stewardship Pharmacist: Advancing Pain Management and Safe Opioid Use in Cancer Care
November 7th 2024Opioid stewardship pharmacist Maureen Saphire, PharmD, BCGP, focuses on advocating for appropriate opioid access for patients with cancer and sickle cell disease, promoting safe opioid use, and supporting leadership and strategic planning as keys to successful opioid stewardship.
Read More
RSV Preventative Monoclonal Antibody Could Reduce Disease Incidence in Preterm, Full-term Infants
November 6th 2024Clesrovimab reduced RSV-associated hospitalizations and RSV-associated lower respiratory infection hospitalizations by more than 84% and 90% in preterm and full-term infants, respectively.
Read More